A 0 1 0 1 O
negative 2 10 2 10 B-pregnancy
serum 11 16 11 16 I-pregnancy
pregnancy 17 26 17 26 I-pregnancy
test 27 31 27 31 O
is 32 34 32 34 O
required 35 43 35 43 O
no 44 46 44 46 O
more 47 51 47 51 O
than 52 56 52 56 O
7 57 58 57 58 B-lower_bound
days 59 63 59 63 I-lower_bound
before 64 70 64 70 O
study 71 76 71 76 O
entry 77 82 77 82 O

AST 0 3 83 86 B-clinical_variable
/ 3 4 86 87 I-clinical_variable
ALT 4 7 87 90 I-clinical_variable
≤2.5 8 12 91 95 O
X 13 14 96 97 I-upper_bound
institutional 15 28 98 111 I-upper_bound
upper 29 34 112 117 I-upper_bound
limit 35 40 118 123 I-upper_bound
of 41 43 124 126 I-upper_bound
normal 44 50 127 133 I-upper_bound

Adequate 0 8 134 142 O
organ 9 14 143 148 O
and 15 18 149 152 O
marrow 19 25 153 159 O
function 26 34 160 168 O
no 35 37 169 171 O
more 38 42 172 176 O
than 43 47 177 181 O
14 48 50 182 184 B-lower_bound
days 51 55 185 189 I-lower_bound
prior 56 61 190 195 I-lower_bound
to 62 64 196 198 O
registration 65 77 199 211 O

At 0 2 212 214 O
least 3 8 215 220 O
18 9 11 221 223 B-lower_bound
years 12 17 224 229 I-lower_bound
of 18 20 230 232 O
age 21 24 233 236 B-age

Clinical 0 8 237 245 B-clinical_variable
stage 9 14 246 251 I-clinical_variable
T2 15 17 252 254 B-lower_bound
- 17 18 254 255 O
T4c 18 21 255 258 B-upper_bound
, 21 22 258 259 O
any 23 26 260 263 O
N 27 28 264 265 O
, 28 29 265 266 O
M0 30 32 267 269 O
primary 33 40 270 277 B-cancer
tumor 41 46 278 283 I-cancer
by 47 49 284 286 O
AJCC 50 54 287 291 O
7th 55 58 292 295 O
edition 59 66 296 303 O
clinical 67 75 304 312 O
staging 76 83 313 320 O
prior 84 89 321 326 O
to 90 92 327 329 O
neoadjuvant 93 104 330 341 B-treatment
chemotherapy 105 117 342 354 I-treatment
, 117 118 354 355 O
with 119 123 356 360 O
residual 124 132 361 369 O
invasive 133 141 370 378 O
breast 142 148 379 385 B-cancer
cancer 149 155 386 392 I-cancer
after 156 161 393 398 O
neoadjuvant 162 173 399 410 B-treatment
therapy 174 181 411 418 I-treatment
. 181 182 418 419 O
If 183 185 420 422 O
the 186 189 423 426 O
patient 190 197 427 434 O
has 198 201 435 438 O
invasive 202 210 439 447 O
cancer 211 217 448 454 O
in 218 220 455 457 O
the 221 224 458 461 O
contralateral 225 238 462 475 O
breast 239 245 476 482 O
, 245 246 482 483 O
she 247 250 484 487 O
is 251 253 488 490 O
not 254 257 491 494 O
eligible 258 266 495 503 O
for 267 270 504 507 O
this 271 275 508 512 O
study 276 281 513 518 O

Consented 0 9 519 528 O
for 10 13 529 532 O
genome 14 20 533 539 O
sequencing 21 31 540 550 O
and 32 35 551 554 O
dbGAP 36 41 555 560 O
- 41 42 560 561 O
based 42 47 561 566 O
data 48 52 567 571 O
sharing 53 60 572 579 O
and 61 64 580 583 O
has 65 68 584 587 O
provided 69 77 588 596 O
or 78 80 597 599 O
will 81 85 600 604 O
provide 86 93 605 612 O
germline 94 102 613 621 O
and 103 106 622 625 O
tumor 107 112 626 631 B-cancer
DNA 113 116 632 635 B-clinical_variable
samples 117 124 636 643 O
of 125 127 644 646 O
adequate 128 136 647 655 O
quality 137 144 656 663 O
for 145 148 664 667 O
sequencing 149 159 668 678 O
. 159 160 678 679 O
Fresh 161 166 680 685 O
tissue 167 173 686 692 O
is 174 176 693 695 O
preferred 177 186 696 705 O
( 187 188 706 707 O
from 188 192 707 711 O
biopsy 193 199 712 718 B-treatment
at 200 202 719 721 O
the 203 206 722 725 O
time 207 211 726 730 O
of 212 214 731 733 O
port 215 219 734 738 O
placement 220 229 739 748 O
) 229 230 748 749 O
but 231 234 750 753 O
archival 235 243 754 762 O
tissue 244 250 763 769 O
is 251 253 770 772 O
allowed 254 261 773 780 O

ER 0 2 781 783 B-clinical_variable
and 3 6 784 787 O
PR 7 9 788 790 B-clinical_variable
less 10 14 791 795 O
than 15 19 796 800 O
Allred 20 26 801 807 O
score 27 32 808 813 O
of 33 35 814 816 O
3 36 37 817 818 B-lower_bound
or 38 40 819 821 O
less 41 45 822 826 O
than 46 50 827 831 O
1 51 52 832 833 B-lower_bound
% 52 53 833 834 I-lower_bound
positive 54 62 835 843 O
staining 63 71 844 852 O
cells 72 77 853 858 O
in 78 80 859 861 O
the 81 84 862 865 O
invasive 85 93 866 874 O
component 94 103 875 884 O
of 104 106 885 887 O
the 107 110 888 891 O
tumor 111 116 892 897 B-cancer

Eastern 0 7 898 905 B-clinical_variable
Cooperative 8 19 906 917 I-clinical_variable
Oncology 20 28 918 926 I-clinical_variable
Group 29 34 927 932 I-clinical_variable
( 35 36 933 934 I-clinical_variable
ECOG 36 40 934 938 I-clinical_variable
) 40 41 938 939 I-clinical_variable
performance 42 53 940 951 I-clinical_variable
status 54 60 952 958 I-clinical_variable
≤ 61 62 959 960 O
2 63 64 961 962 B-upper_bound

Evidence 0 8 963 971 O
of 9 11 972 974 O
progressive 12 23 975 986 O
breast 24 30 987 993 B-cancer
cancer 31 37 994 1000 I-cancer
within 38 44 1001 1007 O
the 45 48 1008 1011 O
last 49 53 1012 1016 B-upper_bound
30 54 56 1017 1019 I-upper_bound
days 57 61 1020 1024 I-upper_bound

Experiencing 0 12 1025 1037 O
adverse 13 20 1038 1045 O
events 21 27 1046 1052 O
due 28 31 1053 1056 O
to 32 34 1057 1059 O
agents 35 41 1060 1066 O
administered 42 54 1067 1079 O
more 55 59 1080 1084 O
than 60 64 1085 1089 O
30 65 67 1090 1092 B-lower_bound
days 68 72 1093 1097 I-lower_bound
earlier 73 80 1098 1105 O

HER2 0 4 1106 1110 O
negative 5 13 1111 1119 O
by 14 16 1120 1122 O
FISH 17 21 1123 1127 B-treatment
or 22 24 1128 1130 O
IHC 25 28 1131 1134 B-treatment
staining 29 37 1135 1143 O
0 38 39 1144 1145 B-lower_bound
or 40 42 1146 1148 O
1 43 44 1149 1150 B-upper_bound
+ 44 45 1150 1151 I-upper_bound

Histologically 0 14 1152 1166 O
confirmed 15 24 1167 1176 O
diagnosis 25 34 1177 1186 O
of 35 37 1187 1189 O
invasive 38 46 1190 1198 B-cancer
breast 47 53 1199 1205 I-cancer
cancer 54 60 1206 1212 I-cancer

Invasive 0 8 1213 1221 B-cancer
cancer 9 15 1222 1228 I-cancer
in 16 18 1229 1231 I-cancer
the 19 22 1232 1235 I-cancer
contralateral 23 36 1236 1249 I-cancer
breast 37 43 1250 1256 I-cancer

Known 0 5 1257 1262 O
HIV 6 9 1263 1266 B-chronic_disease
- 9 10 1266 1267 O
positive 10 18 1267 1275 O
status 19 25 1276 1282 O
. 25 26 1282 1283 O
These 27 32 1284 1289 O
patients 33 41 1290 1298 O
are 42 45 1299 1302 O
ineligible 46 56 1303 1313 O
because 57 64 1314 1321 O
of 65 67 1322 1324 O
the 68 71 1325 1328 O
potential 72 81 1329 1338 O
inability 82 91 1339 1348 O
to 92 94 1349 1351 O
generate 95 103 1352 1360 O
an 104 106 1361 1363 O
immune 107 113 1364 1370 O
response 114 122 1371 1379 O
to 123 125 1380 1382 O
vaccines 126 134 1383 1391 B-treatment

Known 0 5 1392 1397 O
allergy 6 13 1398 1405 O
, 13 14 1405 1406 O
or 15 17 1407 1409 O
history 18 25 1410 1417 O
of 26 28 1418 1420 O
serious 29 36 1421 1428 O
adverse 37 44 1429 1436 O
reaction 45 53 1437 1445 O
to 54 56 1446 1448 O
vaccines 57 65 1449 1457 B-allergy_name
such 66 70 1458 1462 O
as 71 73 1463 1465 O
anaphylaxis 74 85 1466 1477 B-allergy_name
, 85 86 1477 1478 O
hives 87 92 1479 1484 B-allergy_name
, 92 93 1484 1485 O
or 94 96 1486 1488 O
respiratory 97 108 1489 1500 B-allergy_name
difficulty 109 119 1501 1511 I-allergy_name

Known 0 5 1512 1517 O
metastatic 6 16 1518 1528 B-cancer
disease 17 24 1529 1536 I-cancer

Patient 0 7 1537 1544 O
must 8 12 1545 1549 O
have 13 17 1550 1554 O
no 18 20 1555 1557 O
active 21 27 1558 1564 O
major 28 33 1565 1570 O
medical 34 41 1571 1578 B-chronic_disease
or 42 44 1579 1581 O
psychosocial 45 57 1582 1594 B-chronic_disease
problems 58 66 1595 1603 I-chronic_disease
that 67 71 1604 1608 O
could 72 77 1609 1614 O
be 78 80 1615 1617 O
complicated 81 92 1618 1629 O
by 93 95 1630 1632 O
study 96 101 1633 1638 O
participation 102 115 1639 1652 O

Pregnant 0 8 1653 1661 B-pregnancy

Prior 0 5 1662 1667 O
or 6 8 1668 1670 O
currently 9 18 1671 1680 O
active 19 25 1681 1687 O
autoimmune 26 36 1688 1698 B-chronic_disease
disease 37 44 1699 1706 I-chronic_disease
requiring 45 54 1707 1716 O
management 55 65 1717 1727 O
with 66 70 1728 1732 O
immunosuppression 71 88 1733 1750 B-treatment
. 88 89 1750 1751 O
This 90 94 1752 1756 O
includes 95 103 1757 1765 O
inflammatory 104 116 1766 1778 B-chronic_disease
bowel 117 122 1779 1784 I-chronic_disease
disease 123 130 1785 1792 I-chronic_disease
, 130 131 1792 1793 O
ulcerative 132 142 1794 1804 B-chronic_disease
colitis 143 150 1805 1812 I-chronic_disease
, 150 151 1812 1813 O
Crohn 152 157 1814 1819 B-chronic_disease
's 157 159 1819 1821 I-chronic_disease
disease 160 167 1822 1829 I-chronic_disease
, 167 168 1829 1830 O
systemic 169 177 1831 1839 B-chronic_disease
vasculitis 178 188 1840 1850 I-chronic_disease
, 188 189 1850 1851 O
scleroderma 190 201 1852 1863 B-chronic_disease
, 201 202 1863 1864 O
psoriasis 203 212 1865 1874 B-chronic_disease
, 212 213 1874 1875 O
multiple 214 222 1876 1884 B-chronic_disease
sclerosis 223 232 1885 1894 I-chronic_disease
, 232 233 1894 1895 O
hemolytic 234 243 1896 1905 B-chronic_disease
anemia 244 250 1906 1912 I-chronic_disease
, 250 251 1912 1913 O
immune 252 258 1914 1920 B-chronic_disease
- 258 259 1920 1921 I-chronic_disease
mediated 259 267 1921 1929 I-chronic_disease
thrombocytopenia 268 284 1930 1946 I-chronic_disease
, 284 285 1946 1947 O
rheumatoid 286 296 1948 1958 B-chronic_disease
arthritis 297 306 1959 1968 I-chronic_disease
, 306 307 1968 1969 O
systemic 308 316 1970 1978 B-chronic_disease
lupus 317 322 1979 1984 I-chronic_disease
erythematosus 323 336 1985 1998 I-chronic_disease
, 336 337 1998 1999 O
Sjorgen 338 345 2000 2007 B-chronic_disease
's 345 347 2007 2009 I-chronic_disease
syndrome 348 356 2010 2018 I-chronic_disease
, 356 357 2018 2019 O
sarcoidosis 358 369 2020 2031 B-chronic_disease
, 369 370 2031 2032 O
or 371 373 2033 2035 O
other 374 379 2036 2041 O
rheumatologic 380 393 2042 2055 B-chronic_disease
disease 394 401 2056 2063 I-chronic_disease
or 402 404 2064 2066 O
any 405 408 2067 2070 O
other 409 414 2071 2076 O
medical 415 422 2077 2084 B-chronic_disease
condition 423 432 2085 2094 I-chronic_disease
or 433 435 2095 2097 O
use 436 439 2098 2101 O
of 440 442 2102 2104 O
medication 443 453 2105 2115 B-treatment
( 454 455 2116 2117 O
e.g. 455 459 2117 2121 O
, 459 460 2121 2122 O
corticosteroids 461 476 2123 2138 B-treatment
) 476 477 2138 2139 O
which 478 483 2140 2145 O
might 484 489 2146 2151 O
make 490 494 2152 2156 O
it 495 497 2157 2159 O
difficult 498 507 2160 2169 O
for 508 511 2170 2173 O
the 512 515 2174 2177 O
patient 516 523 2178 2185 O
to 524 526 2186 2188 O
complete 527 535 2189 2197 O
the 536 539 2198 2201 O
full 540 544 2202 2206 O
course 545 551 2207 2213 O
of 552 554 2214 2216 O
treatments 555 565 2217 2227 B-treatment
or 566 568 2228 2230 O
to 569 571 2231 2233 O
generate 572 580 2234 2242 O
an 581 583 2243 2245 O
immune 584 590 2246 2252 O
response 591 599 2253 2261 O
to 600 602 2262 2264 O
vaccines 603 611 2265 2273 B-treatment
. 611 612 2273 2274 O
Asthma 613 619 2275 2281 B-chronic_disease
or 620 622 2282 2284 O
chronic 623 630 2285 2292 B-chronic_disease
obstructive 631 642 2293 2304 I-chronic_disease
pulmonary 643 652 2305 2314 I-chronic_disease
disease 653 660 2315 2322 I-chronic_disease
that 661 665 2323 2327 O
does 666 670 2328 2332 O
not 671 674 2333 2336 O
require 675 682 2337 2344 O
daily 683 688 2345 2350 O
systemic 689 697 2351 2359 B-treatment
corticosteroids 698 713 2360 2375 I-treatment
is 714 716 2376 2378 O
acceptable 717 727 2379 2389 O
. 727 728 2389 2390 O
Any 729 732 2391 2394 O
patients 733 741 2395 2403 O
receiving 742 751 2404 2413 O
steroids 752 760 2414 2422 O
should 761 767 2423 2429 O
be 768 770 2430 2432 O
discussed 771 780 2433 2442 O
with 781 785 2443 2447 O
the 786 789 2448 2451 O
PI 790 792 2452 2454 O
to 793 795 2455 2457 O
determine 796 805 2458 2467 O
if 806 808 2468 2470 O
eligible 809 817 2471 2479 O

Received 0 8 2480 2488 O
chemotherapy 9 21 2489 2501 B-treatment
, 21 22 2501 2502 O
radiotherapy 23 35 2503 2515 B-treatment
, 35 36 2515 2516 O
or 37 39 2517 2519 O
biologic 40 48 2520 2528 B-treatment
therapy 49 56 2529 2536 I-treatment
within 57 63 2537 2543 O
the 64 67 2544 2547 O
last 68 72 2548 2552 O
30 73 75 2553 2555 B-upper_bound
days 76 80 2556 2560 I-upper_bound
( 81 82 2561 2562 O
neoadjuvant 82 93 2562 2573 B-treatment
chemotherapy 94 106 2574 2586 I-treatment
excluded 107 115 2587 2595 O
) 115 116 2595 2596 O

Receiving 0 9 2597 2606 O
any 10 13 2607 2610 O
other 14 19 2611 2616 O
investigational 20 35 2617 2632 B-treatment
agent(s 36 43 2633 2640 I-treatment
) 43 44 2640 2641 I-treatment
or 45 47 2642 2644 O
has 48 51 2645 2648 O
received 52 60 2649 2657 O
an 61 63 2658 2660 O
investigational 64 79 2661 2676 O
agent 80 85 2677 2682 O
within 86 92 2683 2689 O
the 93 96 2690 2693 O
last 97 101 2694 2698 B-upper_bound
30 102 104 2699 2701 I-upper_bound
days 105 109 2702 2706 I-upper_bound

The 0 3 2707 2710 O
patient 4 11 2711 2718 O
with 12 16 2719 2723 O
a 17 18 2724 2725 O
previous 19 27 2726 2734 O
history 28 35 2735 2742 O
of 36 38 2743 2745 O
non 39 42 2746 2749 O
- 42 43 2749 2750 O
breast 43 49 2750 2756 O
malignancy 50 60 2757 2767 B-cancer
is 61 63 2768 2770 O
eligible 64 72 2771 2779 O
for 73 76 2780 2783 O
this 77 81 2784 2788 O
study 82 87 2789 2794 O
only 88 92 2795 2799 O
if 93 95 2800 2802 O
the 96 99 2803 2806 O
patient 100 107 2807 2814 O
meets 108 113 2815 2820 O
the 114 117 2821 2824 O
following 118 127 2825 2834 O
criteria 128 136 2835 2843 O
for 137 140 2844 2847 O
a 141 142 2848 2849 O
cancer 143 149 2850 2856 B-cancer
survivor 150 158 2857 2865 O

Uncontrolled 0 12 2866 2878 O
intercurrent 13 25 2879 2891 B-chronic_disease
illness 26 33 2892 2899 I-chronic_disease
including 34 43 2900 2909 O
, 43 44 2909 2910 O
but 45 48 2911 2914 O
not 49 52 2915 2918 O
limited 53 60 2919 2926 O
to 61 63 2927 2929 O
ongoing 64 71 2930 2937 O
or 72 74 2938 2940 O
active 75 81 2941 2947 B-chronic_disease
infection 82 91 2948 2957 I-chronic_disease
, 91 92 2957 2958 O
symptomatic 93 104 2959 2970 O
congestive 105 115 2971 2981 B-chronic_disease
heart 116 121 2982 2987 I-chronic_disease
failure 122 129 2988 2995 I-chronic_disease
, 129 130 2995 2996 O
unstable 131 139 2997 3005 B-chronic_disease
angina 140 146 3006 3012 I-chronic_disease
pectoris 147 155 3013 3021 I-chronic_disease
, 155 156 3021 3022 O
cardiac 157 164 3023 3030 B-chronic_disease
arrhythmia 165 175 3031 3041 I-chronic_disease
( 176 177 3042 3043 O
including 177 186 3043 3052 O
sinus 187 192 3053 3058 B-chronic_disease
bradycardia 193 204 3059 3070 I-chronic_disease
) 204 205 3070 3071 O
, 205 206 3071 3072 O
or 207 209 3073 3075 O
psychiatric 210 221 3076 3087 B-chronic_disease
illness 222 229 3088 3095 I-chronic_disease
/ 229 230 3095 3096 O
social 230 236 3096 3102 O
situation 237 246 3103 3112 O
that 247 251 3113 3117 O
would 252 257 3118 3123 O
limit 258 263 3124 3129 O
compliance 264 274 3130 3140 O
with 275 279 3141 3145 O
study 280 285 3146 3151 O
requirements 286 298 3152 3164 O

WBC 0 3 3165 3168 B-clinical_variable
≥3,000 4 10 3169 3175 O
/ 10 11 3175 3176 I-lower_bound
μL 11 13 3176 3178 I-lower_bound

Women 0 5 3179 3184 B-gender
of 6 8 3185 3187 O
reproductive 9 21 3188 3200 O
potential 22 31 3201 3210 O
must 32 36 3211 3215 O
agree 37 42 3216 3221 B-contraception_consent
to 43 45 3222 3224 I-contraception_consent
use 46 49 3225 3228 I-contraception_consent
adequate 50 58 3229 3237 I-contraception_consent
contraception 59 72 3238 3251 I-contraception_consent
( 73 74 3252 3253 O
hormonal 74 82 3253 3261 B-contraception_consent
or 83 85 3262 3264 O
barrier 86 93 3265 3272 B-contraception_consent
method 94 100 3273 3279 I-contraception_consent
of 101 103 3280 3282 I-contraception_consent
birth 104 109 3283 3288 I-contraception_consent
control 110 117 3289 3296 I-contraception_consent
; 117 118 3296 3297 O
abstinence 119 129 3298 3308 B-contraception_consent
) 129 130 3308 3309 O
prior 131 136 3310 3315 O
to 137 139 3316 3318 O
study 140 145 3319 3324 O
entry 146 151 3325 3330 O
and 152 155 3331 3334 O
for 156 159 3335 3338 O
the 160 163 3339 3342 O
duration 164 172 3343 3351 O
of 173 175 3352 3354 O
study 176 181 3355 3360 O
participation 182 195 3361 3374 O

absolute 0 8 3375 3383 B-clinical_variable
neutrophil 9 19 3384 3394 I-clinical_variable
count 20 25 3395 3400 I-clinical_variable
≥1,500 26 32 3401 3407 O
/ 32 33 3407 3408 I-lower_bound
μL 33 35 3408 3410 I-lower_bound

creatinine 0 10 3411 3421 B-clinical_variable
≤1.5 11 15 3422 3426 O
X 16 17 3427 3428 I-upper_bound
institutional 18 31 3429 3442 I-upper_bound
upper 32 37 3443 3448 I-upper_bound
limit 38 43 3449 3454 I-upper_bound
of 44 46 3455 3457 I-upper_bound
normal 47 53 3458 3464 I-upper_bound

platelets 0 9 3465 3474 B-clinical_variable
≥100,000 10 18 3475 3483 O
/ 18 19 3483 3484 I-lower_bound
μL 19 21 3484 3486 I-lower_bound

total 0 5 3487 3492 B-clinical_variable
bilirubin 6 15 3493 3502 I-clinical_variable
≤2.5 16 20 3503 3507 O
X 21 22 3508 3509 I-upper_bound
institutional 23 36 3510 3523 I-upper_bound
upper 37 42 3524 3529 I-upper_bound
limit 43 48 3530 3535 I-upper_bound
of 49 51 3536 3538 I-upper_bound
normal 52 58 3539 3545 I-upper_bound

